Clinical and Translational Radiation Oncology

Article	Citations
Stabilised Hyaluronic Acid (sHA) gel as a novel marker for breast cancer tumour bed cavity: Surgical feasibility	31
Uterus motion analysis for radiotherapy planning optimization. The innovative contribution of on-board hybrid MR imaging	29
Influence of intestinal microbial metabolites on the abscopal effect after radiation therapy combined with immune checkpoint inhibitors	26
Measuring patient reported outcomes in brachytherapy: Why we should do it and more importantly how	23
Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments	22
Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma	20
Avoiding prostate bed radiation for the PSMA-PET detected nodal recurrence patient post prostatectomy	17
Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)	16
Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective study	16
Developing and validating a simple urethra surrogate model to facilitate dosimetric analysis to predict genitourinary toxicity	16
CD8-positive lymphocyte infiltration as a marker of anti-tumor immune response in rectal cancer: pre- and post-neoadjuvant radiotherapy comparison	16
Long-term outcomes of more than a decade treating patients with stereotactic body radiation therapy for hepatocellular carcinoma	15
Effectiveness, toxicity and impact on quality of life of high-dose-rate brachytherapy delivered in two fractions as monotherapy in patients with prostate cancer	15
Systemic therapy escalation after stereotactic body radiation therapy for oligometastatic hormone-sensitive prostate cancer	14
Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac	13
Association between radiotherapy protocol variations and outcome in the CONVERT trial	13
Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial	13
Radiation response assessment of organoids derived from patients with pancreatic cancer	12
Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancer	11
A fully automated machine-learning-based workflow for radiation treatment planning in prostate cancer	11
Bulky non-small cell lung cancer treated with two-field robust proton lattice boost followed by conventional chemoradiation	11
Predicting radiation-induced hypothyroidism in nasopharyngeal carcinoma patients using a deep learning model	11
Trends in use of magnetic resonance imaging and partial breast irradiation between 2011–2022 in the Netherlands: A population-based study	10
Assessment of the impact of age on DIBH in radiotherapy based on the prospective GATTUM and B-REST trials	10
Blood-brain barrier permeability following conventional photon radiotherapy – A systematic review and meta-analysis of clinical and preclinical studies	10

Predicting late renal toxicity using a two-component repair model among pediatric patients receiving total body irradiation for stem cell transplant	10
Letter to the editor: Reply to Chen et al.	10
Comparison of simultaneous integrated tumor bed boost and sequential boost during hypofractionated whole-breast irradiation after breast-conserving surgery	10
MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study	10
Investigation of the physiological response of radiation-induced cystitis patients using hyperbaric oxygen	9
Changes in prostate volume during prostate SBRT delivered on an MR-Linac and correlation with acute toxicity	9
Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLC	8
Artificial intelligence to predict outcomes of head and neck radiotherapy	8
Comparative effectiveness of new treatment modalities for localized prostate cancer through patient-reported outcome measures	8
Adaptive FDG-PET/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study)	8
Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer	8
Integrative prediction model for radiation pneumonitis incorporating genetic and clinical-pathological factors using machine learning	8
Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatment	8
Acute toxicity patterns and their management after moderate and ultra- hypofractionated radiotherapy for prostate cancer: A prospective cohort study	8
Outcomes and predictors of response to fractionated radiotherapy as primary treatment for intracranial meningiomas	8
Metastases-directed radiotherapy in castration resistant oligo metastatic prostate cancer: A multicentric retrospective study from the French group COLib	7
Comparing supervised and semi-supervised machine learning approaches in NTCP modeling to predict complications in head and neck cancer patients	7
Acute toxicities in proton therapy for head and neck cancer – A matched analysis of the DAHANCA 35 feasibility study	7
Comparison of 18F-FET-PET- and MRI-based target definition for re-irradiation treatment of recurrent diffuse glioma	7
Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration‐resistant prostate cancer patients – A closer inspection will improve your vision	7
Simultaneous integrated boost and protection proton beam therapy approach for hepatocellular carcinoma	7
Clinical outcomes of esophageal squamous cell carcinoma in patients with cirrhosis	7
Stereotactic ablative radiotherapy for treating primary head and neck cancer and locoregional recurrence: A comprehensive review of the literature	7
Clinical management of oligometastatic cancer: Applying multidisciplinary tumor board recommendations in practice	7
Setting the stage: The opening act of preoperative SRS for brain metastases	7
Corrigendum to “Bridging the care gap: patients’ needs and experiences regarding shared decision-making in radiotherapy” [Clin. Translat. Radiat. Oncol. (2025) 100897]	6
Efficacy of radiotherapy and radiotherapy with hyperthermia to delay change of systemic therapy in patients with metastatic melanoma	6
Concurrent palliative radiation with pembrolizumab for platinum-refractory urothelial carcinoma is associated with improved overall survival	6
Access to brachytherapy treatment for cervical cancer management in Africa	6
Cetuximab, gemcitabine and radiotherapy in locally advanced pancreatic cancer: Long-term results of the randomized controlled phase II PARC trial	6
In regard to Kim et al	6
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer	6
Immunohistochemical analyses of paraffin-embedded sections after primary surgery or trimodality treatment in esophageal carcinoma	6
Randomized clinical trial of tissue equivalent bolus prescription in postmastectomy radiotherapy stratified by skin involvement status	6
Refractory ventricular tachycardia treated by a second session of stereotactic arrhythmia radioablation	6
Quantifying radiation-induced breast fibrosis by shear-wave elastography in patients with breast cancer: A 12-months-follow-up data of a prospective study	6
The prognostic utility of IGF-1 in hepatocellular carcinoma treated with stereotactic body radiotherapy	6
Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI	6
Feasibility of low-dose radiotherapy for patients with stage I/II extranodal NK-/T-cell lymphoma, nasal type achieving complete response after l-asparaginase-containing chemotherapy	6
Risk of stroke-specific mortality after radiotherapy in patients with primary brain tumours	6
Complications leading to hospitalisation 12 months after brachytherapy or high-intensity focused ultrasound for localized prostate cancer: French national from the PMSI-MCO data, 2019 and 2020	6
Predicting the benefit of stereotactic body radiotherapy of colorectal cancer metastases	5
Does a peer review group consensus process for MR-Linac patients affect clinical care? Evaluation of impact and feasibility	5
Multidisciplinary Treatment of Non-Spine Bone Metastases: Results of a Modified Delphi Consensus Process	5
Salvage LATTICE radiotherapy for a growing tumour despite conventional radio chemotherapy treatment of lung cancer	5
Outcomes and predictive factors after second stereotactic radiosurgery for refractory trigeminal neuralgia	5
Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in Australia	5
A prospective study assessing the pattern of response of local disease at DCE-MRI after salvage radiotherapy for prostate cancer	5
MucoUp® as a spacer in brachytherapy for uterine cervical cancer: A first-in-human experience	5
Postoperative complications after esophagectomy for cancer, neoadjuvant chemoradiotherapy compared to neoadjuvant chemotherapy: A single institutional cohort study	5

The carbon footprint of external beam radiotherapy and its impact in health technology assessment	5
Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer	5
Acute toxicity and quality of life in dose-escalated proton reirradiation for locally recurrent rectal cancer: The prospective ReRad II trial	5
The role of radiotherapy in the management of metastatic rectal cancer: A narrative review on the opportunities for non-operative management and organ preservation	5
Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study	5
Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis	5
Development and validation of cost-effective multi-sample hypoxia chambers for proton ultra-high dose rate organoid irradiations	5
The need for consensus on delineation and dose constraints of dentofacial structures in paediatric radiotherapy: Outcomes of a SIOP Europe survey	5
Changes in splenic volumes following stereotactic ablative radiotherapy (SABR) to adrenal tumors	5
Artificial intelligence guided physician directive improves head and neck planning quality and practice Uniformity: A prospective study	5
Primary site stereotactic ablative body radiotherapy in localized, recurrent, and metastatic renal cell carcinoma	5
Fractionated stereotactic radiotherapy of intracranial postoperative cavities after resection of brain metastases – Clinical outcome and prognostic factors	5
Daily adaptive MR-guided stereotactic ablative re-irradiation (re-SABR) in oligometastatic liver disease: A single-institution retrospective analysis	5
Reproducibility of Deep-Inspiration Breath Hold treatments on Halcyon™ performed using the first clinical version of AlignRT InBore™: Results of CYBORE study	5
Acute and late toxicity patterns of moderate hypo-fractionated radiotherapy for prostate cancer: A systematic review and meta-analysis	5
Irradiation of localized prostate cancer in the elderly: A systematic literature review	5
External validation of pulmonary radiotherapy toxicity models for ultracentral lung tumors	4
Pelvic insufficiency fractures after intensity modulated radiation therapy combined with chemotherapy for cervix carcinoma: Incidence and impact of bone mineral density	4
MAPK11 (p38β) is a major determinant of cellular radiosensitivity by controlling ionizing radiation-associated senescence: An in vitro study	4
C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect	4
Combining CAR-T therapy with radiotherapy or not in refractory/relapsed diffuse large B-cell lymphoma: A comparative study	4
Enhancing radiotherapy outcomes in rectal cancer: A systematic review of targeting hypoxia-induced radioresistance	4
Postoperative radiotherapy alone is as effective as postoperative chemoradiotherapy in patients with pT4aN0 gingival cancer with negative surgical margins	4
Determining risk and predictors of head and neck cancer treatment-related lymphedema: A clinicopathologic and dosimetric data mining approach using interpretable machine learning and ensemble feature	4
Health care system factors associated with receipt of treatment and treatment intent in stage III non-small cell lung cancer: A population-based study in Ontario	4
Prospective radiotherapy quality Assurance leads to delineation guideline refinements for recurrent rectal cancer: Experience from the PelvEx II study	4
Exploring causes and consequences of early discontinuation of durvalumab after chemoradiotherapy for non-small cell lung cancer	4
Adjuvant PD-1 antibody in recurrent, previously irradiated oral cavity cancer treated with salvage surgery	4
Cleaning radiotherapy contours for radiomics studies, is it worth it? A head and neck cancer study	4
Patient experience and shared decision-making in HPV-positive oropharyngeal cancer: A systematic review of qualitative and quantitative evidence	4
Personalized neck irradiation guided by sentinel lymph node biopsy in patients with squamous cell carcinoma of the oropharynx, larynx or hypopharynx with a clinically negative neck: (Chemo)radiotherap	4
Bridging the care gap: patients’ needs and experiences regarding shared decision-making in radiotherapy	4
Helical tomotherapy for post-mastectomy radiation therapy with or without breast implant: a single institution experience	4
GI factors, potential to predict prostate motion during radiotherapy; a scoping review	4
A GORTEC survey on low-risk CTV-P2 delineation in head and neck cancers	4
Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey	4
Clinical outcomes and risk factors for local failure and visual impairment in patients treated with Ru-106 brachytherapy for uveal melanoma	4
The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation	4
Prognostic factors, patterns of failure and re-irradiation in hypofractionated stereotactic radiotherapy-treated brain metastases from non-small cell lung cancer	4
Cosmetic outcome in patients with early stage breast cancer after accelerated partial breast irradiation using intraoperative or external beam radiotherapy	4
Comparing pre-operative versus post-operative single and multi-fraction stereotactic radiotherapy for patients with resectable brain metastases	4
Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy	4
Reirradiation with stereotactic radiosurgery for vestibular schwannomas – a systematic review and meta-analysis	4
Mepitel® film versus standard care for the prevention of skin toxicity in breast cancer patients treated with adjuvant radiotherapy: A randomized controlled trial	4
Cervical body composition on radiotherapy planning computed tomography scans predicts overall survival in glioblastoma patients	4
Supraventricular cardiac conduction system exposure in breast cancer patients treated with radiotherapy and association with heart and cardiac chambers doses	4
Letter to the Editor	4
Salvage radiotherapy for relapsed/refractory non‐Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy	4
An exploratory analysis of MR-guided fractionated stereotactic radiotherapy in patients with brain metastases	4
Mid-treatment adaptive planning during thoracic radiation using 68 Ventilation-Perfusion Positron emission tomography	3
Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer after FOLFIRINOX chemotherapy	3
Re-irradiation of recurrent lung tumours: Associations between dose and 2-year survival	3
Online CBCT-based adaptive radiation with reduced PTV margins for prostate cancer: Does reference plan comparison tell the whole story?	3
Nonoperative versus operative approach according to the response to neoadjuvant chemoradiotherapy for rectal cancer: A prospective cohort study	3
Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institutio	3
Evaluation of loco-regional recurrences using deformable image registration after isotoxic high dose stereotactic body radiotherapy in localised pancreatic cancer	3
Patterns of locoregional recurrences and suggestion of the clinical target volume in resected perihilar extrahepatic cholangiocarcinoma	3
Helical tomotherapy craniospinal irradiation in primary brain tumours: Toxicities and outcomes in a peadiatric and adult population	3
Online adaptive radiotherapy for head and neck cancers on the MR linear Accelerator: Introducing a novel modified Adapt-to-Shape approach	3
Feasibility and safety of single-fraction sub-ablative radiotherapy with systemic therapy in colorectal cancer patients with ≤ 10 metastases: A multicenter pilot study (NCT05375708)	3
High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort	3
Is bilateral radiotherapy necessary for patients with unilateral squamous cell carcinoma of unknown primary of the head and neck region?	3
The oxygen puzzle in FLASH radiotherapy: A comprehensive review and experimental outlook	3
Detection of alteration in carotid artery volumetry using standard-of-care computed tomography surveillance scans following unilateral radiation therapy for early-stage tonsillar squamous cell carcino	3
Biopsy-derived oral keratinocytes – A model to potentially test for oral mucosa radiation sensitivity	3
Pseudo-siamese network combined with dosimetric and clinical factors, radiomics features, CT images and 3D dose distribution for the prediction of radiation pneumonitis: A feasibility study	3
Impact of endorectal filling on interobserver variability of MRI based rectal primary tumor delineation	3
Outcomes of Isocitrate Dehydrogenase Wild Type Glioblastoma after Re-irradiation	3
Reply to: Comment on “Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical disease”	3
Same-Day Magnetic Resonance-Guided Single-Fraction Stereotactic Body Radiation Therapy for Painful Non-Spine Bone Metastases – A Single-Center Study (“BONE SHOT”)	3
Prediction for cardiac and pulmonary toxicity in a multicentric cohort of advanced stage NSCLC patients using sub-regions of the heart	3
Large language models for pretreatment education in pediatric radiation oncology: A comparative evaluation study	3
Splenic irradiation contributes to grade ≥ 3 lymphopenia after adjuvant chemoradiation for stomach cancer	3
PSMA response evaluation in follow-up PSMA-PET/CT after stereotactic ablative body radiotherapy (SABR) for oligometastases in prostate cancer	3
Postoperative SBRT in the treatment of early-stage oropharyngeal and oral cavity cancers with high-risk margins: A dosimetric comparison of volumetric modulated arc therapy with or without non-coplana	3
Evaluation of organ-specific relative biological effectiveness of proton therapy using radiation-induced pneumonitis as an endpoint	3
Late Adverse Health Outcomes and Quality of Life after curative radiotherapy + long-term ADT in Prostate Cancer Survivors: Comparison with men from the general population	3
Optimizing predictive accuracy of the two-component repair model for pediatric TBI: Pediatric-specific parameters, toxicity endpoint harmonization, and dose-rate safeguards	3
Radiation therapy for primary orbital and ocular adnexal lymphoma	3
Enhanced radiosensitivity of head and neck cancer cells to proton therapy via hyperthermia-induced homologous recombination deficiency	3

Thyroid volume changes following adjuvant radiation therapy for breast cancer	3
Reirradiation of recurrent glioblastoma: Results from a single-center retrospective cohort study	3
Adaptive radiotherapy for breast cancer	3
Quality-of-life and toxicity in cancer patients treated with multiple courses of radiation therapy	3
From pre-clinical studies to human treatment with proton-minibeam radiation therapy: adapted Idea, Development, Exploration, Assessment and Long-term evaluation (IDEAL) framework for innovation in rad	3
Increasing patient comfort in palliative radiotherapy with a newly developed mattress: a nonrandomized clinical trial	3
PD-1 and PD-L1 expression predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma	3
Adaptive radiotherapy for oropharyngeal cancer with daily adapt-to-shape workflow on 1.5 T MRI-linac: Preliminary outcomes and comparison with helical tomotherapy	3
Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer – Acute toxicity and patient-reported outcomes in the prospective, multicenter SMILE phase II trial	3
Incidental dose distribution to contralateral internal mammary nodes in breast cancer patients undergoing adjuvant radiotherapy	3
The value of intervention with radiotherapy after first-line chemo-immunotherapy in locally advanced or metastatic esophageal squamous cell carcinoma: A multi-center retrospective study	3
Unmasking enteritis: reply to commentary titled “Clarifying Gastrointestinal toxicity attribution in WP-SBRT: A commentary on Dinesan et al. and proposal of a bladder-bowel displacement index”	3
Acute enteritis with pelvic SBRT: Influence of bowel delineation methods	3
Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospecti	3
Real-world utilisation of brachytherapy boost and patient-reported functional outcomes in men who had external beam radiation therapy for prostate cancer in Australia	3
Ultra-hypofractionated one-week locoregional radiotherapy for patients with early breast cancer: Acute toxicity results	3
Institutional experience of using active breathing control for paediatric and teenage patients receiving thoraco-abdominal radiotherapy	3
Salvage low-dose-rate brachytherapy for locally recurrent prostate cancer after definitive irradiation	3
Young oncologists benefit more than experts from deep learning-based organs-at-risk contouring modeling in nasopharyngeal carcinoma radiotherapy: A multi-institution clinical study exploring working e	3
Volumetric and spatial changes in brain metastases during stereotactic radiosurgery: a case for off-line adaptive planning	3
Dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring of liver tumors using a gimbal-mounted linac: A multi-institutional phase II study	3
Enhanced head and neck radiotherapy target definition through multidisciplinary delineation and peer review: A prospective single-center study	3
Radiotherapy-induced Hypothalamic-Pituitary axis dysfunction in adult Brain, head and neck and skull base tumor patients – A systematic review and Meta-Analysis	3
Exposure of the heart and cardiac valves in women irradiated for breast cancer 1970–2009	3
Design and evaluation of a deep learning-based automatic segmentation of maxillary and mandibular substructures using a 3D U-Net	3
Who should receive single-fraction palliative radiotherapy for gastric cancer bleeding?: An exploratory analysis of a multicenter prospective observational study (JROSG 17-3)	3
SABR for oligometastatic renal cell carcinoma	3
Pelvic lymph node motion during cone-beam computed tomography guided stereotactic radiotherapy	3